AI Article Synopsis

  • The Sorin Bicarbon prosthesis, a bileaflet heart valve, is used in over 80,000 patients but lacks sufficient echocardiographic data on its performance in the aortic position.
  • A study involving 182 patients evaluated the hemodynamic performance of 21-mm and 23-mm Sorin Bicarbon valves over one year, revealing significant decreases in mean and peak gradients.
  • The results showed a notable reduction in left ventricular mass index, highlighting the importance of prosthesis size for effective regression of hypertrophy, with larger valves linked to better outcomes.

Article Abstract

Objective: The Sorin Bicarbon prosthesis (Sorin Biomedica, Saluggia, Italy) is a bileaflet valve with curved-profile leaflets, a rolling hinge mechanism, and a pyrolytic carbon-coated titanium alloy housing and sewing ring. Although the Sorin Bicarbon prosthesis has been implanted in greater than 80,000 patients, and reference values on the hemodynamic performance of valve prostheses are needed to avoid patient-prosthesis mismatch, few Doppler echocardiographic data are available on the prosthesis in the aortic position. The aim of this study is to provide a detailed echocardiographic evaluation of the hemodynamic performance and regression of left ventricular hypertrophy after aortic valve replacement with the Sorin Bicarbon prosthesis.

Methods: The study included 182 patients who received a 21-mm (n = 61) or 23-mm (n = 121) Sorin Bicarbon prosthesis for pure or prevalent aortic stenosis who underwent serial echocardiograms at 3, 6, and 12 months after aortic valve replacement.

Results: Mean and peak gradients significantly decreased (P <.001) during follow-up to values of 12 +/- 3 and 22 +/- 6 mm Hg for the 21-mm prosthesis and values of 11 +/- 4 and 19 +/- 6 mm Hg for the 23-mm prosthesis at 1 year. Left ventricular mass index showed a 17% decrease to 120 +/- 27 g/m(2) in recipients of the 21-mm prosthesis (P <.001) and a 21% decrease to 123 +/- 29 g/m(2) in recipients of the 23-mm prosthesis (P <.001). A larger prosthesis size was the only predictor of a higher left ventricular mass index regression. Among recipients of the 21-mm prosthesis, body surface area of greater than 1.85 m(2) was associated with a lower regression of left ventricular mass index. The effective orifice area index was 1.00 +/- 0.11 and 1.08 +/- 0.14 cm(2)/m(2) in recipients of the 21-mm and 23-mm prostheses, respectively.

Conclusions: Size 21 mm and 23 mm Sorin Bicarbon prostheses show low transprosthetic gradients, with significant reduction of left ventricular mass index during the first postoperative year. The reported effective orifice areas might be useful for aortic valve replacement in patients with a small aortic annulus to avoid patient-prosthesis mismatch.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-5223(02)73395-3DOI Listing

Publication Analysis

Top Keywords

sorin bicarbon
20
bicarbon prosthesis
12
doppler echocardiographic
8
echocardiographic evaluation
8
hemodynamic performance
8
aortic valve
8
sorin
6
bicarbon
5
serial doppler
4
evaluation small-sized
4

Similar Publications

Purpose: We want to share our experience of Sorin Bicarbon prosthesis (SBP) after 19 years follow-up.

Methods: Retrospective study of 1377 patients who had replaced with SBP from May 1998 to December 2008 at Ho Chi Minh Heart Institute, Viet Nam.

Results: Male patients was 42%, mean age was 40.

View Article and Find Full Text PDF

The Polish ventricular assist device (Polvad) has been used successfully in clinical contexts for many years. The device contains two single-disc valves, one at the inlet and one at the outlet connector of the pneumatic pump. Unfortunately, in recent years, a problem has occurred with the availability of single-disc valves.

View Article and Find Full Text PDF

Fifteen-year experience with the Bicarbon heart valve prosthesis in a single center.

J Cardiothorac Surg

June 2015

Division of Cardiovascular Surgery, Department of Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.

Background: The purpose of this study was to evaluate retrospectively the clinical performance of the Bicarbon valve (Sorin Biomedica Cardio, Saluggia, Italy) implanted at our center in Japan.

Methods: Between January 1997 and December 2011, 415 patients in our institution were implanted with the Bicarbon valve. Nine of these recipients were excluded from the study because they had already undergone valve implantation and received a Bicarbon valve in a different position.

View Article and Find Full Text PDF

Objective: To evaluate the long-term results of aortic valve replacement (AVR) and mitral valve replacement (MVR) with the Sorin Bicarbon prosthesis (SBP).

Methods: Five hundred seven patients (306 men, 201 women), mean age 62±10 years (range, 21-86 years), received an SBP between 1994 and 2000; AVR was performed in 344 (67%) and MVR in 163 (33%). The main concomitant procedure was coronary artery grafting in 79 patients (16%).

View Article and Find Full Text PDF

Background And Aim Of The Study: The bileaflet Sorin Bicarbon Overline (Sorin Biomedica Cardio S.p.A.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!